Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Summary of Stock Option Activities (Details)

v3.24.3
Stock-Based Compensation - Summary of Stock Option Activities (Details) - Options
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Options    
Outstanding - beginning balance (in shares) | shares 7,217,074  
Exercised (in shares) | shares (690,463)  
Forfeited (in shares) | shares 0  
Outstanding - ending balance (in shares) | shares 6,526,611 7,217,074
Exercisable at period end (in shares) | shares 6,526,611  
Weighted Average Exercise Price    
Outstanding - beginning balance (in dollars per share) $ 0.19  
Exercised (in dollars per share) 0.18  
Forfeited (in dollars per share) 0  
Outstanding - ending balance (in dollars per share) 0.19 $ 0.19
Exercisable at period end (in dollars per share) 0.19  
Weighted Average Grant Date Fair Value    
Outstanding - beginning balance (in dollars per share) 0.21  
Exercised (in dollars per share) 0.20  
Forfeited (in dollars per share) 0  
Outstanding - ending balance (in dollars per share) 0.21 $ 0.21
Exercisable at period end (in dollars per share) $ 0.21  
Additional Disclosures    
Weighted Average Remaining Life (years) 2 years 8 months 12 days 3 years 6 months
Weighted Average Remaining Life, Exercisable (years) 2 years 8 months 12 days  
Intrinsic Value | $ $ 17,956
Intrinsic Value, Exercisable | $ $ 17,956